The Breathizen Direct Formulation & Supply Desk at breathizendirect.com operates under a strict quantitative audit charter designed to replace exaggerated supplement sales copy with primary physical label evidence, linear boundary mathematics under 21 CFR 101.36(c), peer-reviewed PubMed/PMID clinical benchmarking, and full FTC 16 CFR Part 465 compliance. Below is the complete methodology governing every calculation, citation, and score published across this flagship dossier.
In the direct-to-consumer dietary supplement industry, marketing agencies frequently assemble landing pages using stock copy, unprinted "hero ingredients," or recycled bonus templates that diverge sharply from what the contract manufacturer actually puts inside the bottle. To protect consumers and establish an unassailable factual record, our desk enforces the Printed Label Precedence Rule:
forbreathizen.com) and affiliate checkout funnel against the physical bottle label. Whenever an advertised ingredient (such as Bromelain powder or Organic Cordyceps militaris) or template artifact ("Nervion" nerve copy and 6 weight-loss compounds) is absent from the printed Supplement Facts panel, we document that discrepancy prominently and assign it zero active weight in our formulation score.Under U.S. Food and Drug Administration regulation 21 CFR 101.36(c) [50], dietary supplement manufacturers are permitted to group botanical extracts into a "Proprietary Blend" and declare only the aggregate milligram weight (154 mg per 0.60 mL serving), provided the constituent ingredients are listed in descending order of predominance by weight:
Let w1 represent Mullein leaf 10:1 extract (Position #1), w2 represent Ginger root extract (Position #2), and w3 represent Organic Lemon extract (Position #3), subject to the total mass constraint w1 + w2 + w3 = 154 mg and the regulatory ordering constraint w1 ≥ w2 ≥ w3 ≥ 1.0 mg (assuming a minimum commercially meaningful trace floor of 1.0 mg per declared extract):
w1 = w2 = w3 = 154 / 3 = 51.33 mg) and reaches its theoretical ceiling when Positions #2 and #3 sit at their 1.0 mg trace floor (w1 = 154 - 2.0 = 152.0 mg). Multiply by the 10:1 native extraction ratio to obtain the dried-herb equivalent range of 513 mg to 1,520 mg.2 * w2 + 1.0 = 154 ⇒ w2 = 76.50 mg), and its floor at 1.0 mg.w3 = 154 / 3 = 51.33 mg), and its floor at 1.0 mg.
Every physiological mechanism, pharmacokinetic parameter, and safety warning published on breathizendirect.com is anchored to our 56-source peer-reviewed and regulatory bibliography ([1] through [56]). We classify evidence strictly according to five tiers:
To provide an objective, numerical benchmark across every dietary supplement we audit, our desk assigns weights across five empirical dimensions:
| Audit Dimension | Rubric Weight | Breathizen Score | Primary Audit Criterion |
|---|---|---|---|
| Pillar 1: Ingredient & Excipient Safety | 20% | 6.8 / 10 | Absence of prohibited stimulants, heavy metals, or toxic solvents; clarity of anticoagulant and preservative screening [18] [42]. |
| Pillar 2: Clinical Dose Proportionality | 25% | 3.5 / 10 | Ratio of printed active milligram payload (154 mg blend) to published human RCT doses [9] [12], plus topical glycerol demulcent value [26]. |
| Pillar 3: Label & Funnel Transparency | 25% | 2.8 / 10 | Individual milligram disclosure vs. proprietary blend masking; penalties for unprinted sales-page ingredients (Bromelain, Cordyceps) and template leftovers. |
| Pillar 4: True Per-Serving Unit Economics | 15% | 5.4 / 10 | Delivered cost per printed daily serving ($0.49 to $0.99 across 100 servings per 60 mL bottle) compared against retail DIY botanical stacks. |
| Pillar 5: Refund & Contract Governance | 15% | 5.7 / 10 | Reputation of Merchant of Record (BuyGoods), physical return depot verification (Largo, FL), and deduction of return shipping / packing slip friction. |
Under the Federal Trade Commission's Trade Regulation Rule on the Use of Consumer Reviews and Testimonials (16 CFR Part 465) [54] and Google's structured data guidelines, websites must never invent review counts or attach self-serving AggregateRating stars to commercial product pages. Our audit found only two small Trustpilot profiles for Breathizen, both attached to third-party lovable.app pages rather than the vendor's domain (21 reviews averaging 2.2; 2 reviews averaging 2.9), and no BBB profile. We summarize those reviews in plain text on our buyer audit page, publish zero star-rating schema, and instead present our transparent 4.6 / 10 Quantitative Editorial Score.
breathizendirect.com is funded through affiliate referral commissions earned when readers choose to purchase Breathizen via our outbound BuyGoods allocation links (/claim-allocation/). Compensation never influences our mathematical dose-ceiling calculations, our critical exposure of unprinted sales-page ingredients, or our editorial score. If you identify any factual error, updated label revision, or new clinical publication relevant to Breathizen, email [email protected] for a documented review within 48 hours.
No. breathizendirect.com is an independent formulation and supply audit publication operated by the Breathizen Direct Formulation & Supply Desk. While we earn a referral commission if readers order through our outbound BuyGoods checkout bridge links, our editorial scoring (4.6/10) and forensic label disclosures are 100% independent.
Stars would imply a counted body of verified buyers, and none is tied to the vendor's checkout. The only independent ratings we found on November 8, 2026 sit on Trustpilot profiles for third-party lovable.app pages (21 reviews averaging 2.2, plus 2 averaging 2.9), so displaying a 4.9-star aggregate would misrepresent the evidence under FTC 16 CFR Part 465. Instead, our 4.6/10 score reflects our weighted five-pillar rubric penalizing the 154 mg proprietary blend dose gap and unprinted sales-page claims.
Whenever a supplement's promotional video or sales page claims ingredients, doses, or benefits that conflict with the physical Supplement Facts panel printed on the bottle, our desk treats the physical Supplement Facts panel (154 mg Mullein 10:1, Ginger root, Organic Lemon) as the sole governing specification.
We apply FDA regulation 21 CFR 101.36(c), which mandates that ingredients inside a proprietary blend be listed in descending order of weight (w1 >= w2 >= w3). Using linear boundary constraints across the 154 mg total weight yields exact mathematical ceilings for each position.
Email [email protected] with primary documentation (such as an ISO/IEC 17025 third-party Certificate of Analysis or updated physical bottle label photograph). Verified updates are logged with an archival timestamp within 48 hours.